AAOphth says marijuana is not proven treatment for glaucoma

San Francisco—The American Academy of Ophthalmology (AAOphth) has reiterated its stance on medical marijuana for the treatment of glaucoma, stating that it finds no scientific evidence that marijuana is an effective long-term treatment for the disease, particularly when compared to the current prescription medication and surgical treatment available.» More

Allergan receives FDA approval for Ozurdex for use in certain DME patients

Irvine, CA—Allergan recently announced it has received U.S. Food and Drug Administration (FDA) approval for Ozurdex (dexamethasone intravitreal implant) 0.7 mg as a new treatment option for diabetic macular edema (DME) in adult patients who have an artificial lens implant (pseudophakic) or are scheduled for cataract surgery (phakic). » More

M&S Technologies' Smart System now integrated with Eyemaginations Echo patient education

Niles, IL—M&S Technologies has announced that the latest version of its Smart System 20/20 software is intergrade with Echo patient education from Eyemaginiations. » More

Abbot receives CE Mark for Tecnis Symfony extended range of vision IOL

Abbott Park, IL—Abbott recently announced it has received CE Marking (Conformité Européenne) in Europe for the Tecnis Symfony extended range of vision intraocular lens (IOL) for the treatment of cataract patients who may also have presbyopia.
» More

CONNECT WITH Optometry Times

Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today!

» Facebook

» Twitter